blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3725326

EP3725326 - METHOD AND DRUG FOR PREVENTING OR TREATING OSTEOARTHRITIS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  13.09.2023
Database last updated on 18.11.2024
FormerRequest for examination was made
Status updated on  18.09.2020
FormerThe international publication has been made
Status updated on  21.06.2019
Most recent event   Tooltip24.09.2024Change - representative 
Applicant(s)For all designated states
Talengen International Limited
Suite 2409, Everbright Centre
108 Gloucester Road
Wanchai
Hong Kong / CN
[2020/43]
Inventor(s)01 / LI, Jinan
Room 510, Number 12 Tianbei Third Road, Luohu
District
Shenzhen, Guangdong 518020 / CN
 [2020/43]
Representative(s)karo IP
Patentanwälte PartG mbB
Steinstraße 16-18
40212 Düsseldorf / DE
[N/P]
Former [2020/43]karo IP
karo IP Patentanwälte
Kahlhöfer Rößler Kreuels PartG mbB
Platz der Ideen 2
40476 Düsseldorf / DE
Application number, filing date18888391.217.12.2018
[2020/43]
WO2018CN121535
Priority number, dateWO2017CN11663615.12.2017         Original published format: PCT/CN2017/116636
[2020/43]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019114839
Date:20.06.2019
Language:ZH
[2019/25]
Type: A1 Application with search report 
No.:EP3725326
Date:21.10.2020
Language:EN
[2020/43]
Search report(s)International search report - published on:CN20.06.2019
(Supplementary) European search report - dispatched on:EP27.01.2021
ClassificationIPC:A61K38/48, A61P19/02
[2021/09]
CPC:
A61K38/484 (EP,US); A61P19/02 (EP,US); C12Y304/21007 (US)
Former IPC [2020/43]A61K38/48, A61P19/02, A61P29/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/43]
TitleGerman:VERFAHREN UND ARZNEIMITTEL ZUR VORBEUGUNG ODER BEHANDLUNG VON OSTEOARTHRITIS[2020/43]
English:METHOD AND DRUG FOR PREVENTING OR TREATING OSTEOARTHRITIS[2020/43]
French:MÉTHODE ET MÉDICAMENT POUR PRÉVENIR OU TRAITER L'ARTHROSE[2020/43]
Entry into regional phase15.07.2020Translation filed 
15.07.2020National basic fee paid 
15.07.2020Search fee paid 
15.07.2020Designation fee(s) paid 
15.07.2020Examination fee paid 
Examination procedure15.07.2020Examination requested  [2020/43]
16.08.2021Amendment by applicant (claims and/or description)
04.10.2021Despatch of communication of loss of particular rights: Priority 0001
12.09.2023Despatch of a communication from the examining division (Time limit: M06)
06.02.2024Reply to a communication from the examining division
Request for further processing for:05.11.2021Request for further processing filed
05.11.2021Full payment received (date of receipt of payment)
Request granted
16.11.2021Decision despatched
Fees paidRenewal fee
15.07.2020Renewal fee patent year 03
30.11.2021Renewal fee patent year 04
24.11.2022Renewal fee patent year 05
23.11.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]WO2018108165  (TALENGEN INST LIFE SCIENCES CO LTD [CN]) [XP] 1-15 * example 4; claim - *;
 [E]EP3556381  (TALENGEN INT LTD [CN]) [E] 1-15 * example 4; claim - *;
 [A]  - STEINMEYER J ET AL, "Oral treatment options for degenerative joint disease-presence and future", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM , NL, vol. 58, no. 2, doi:10.1016/J.ADDR.2006.01.007, ISSN 0169-409X, (20060520), pages 168 - 211, (20060520), XP024892181 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.addr.2006.01.007
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.